Padcev OverviewEnfortumab vedotin (AGS-22M6E) is an antibody-drug conjugate designed for the treatment of cancer expressing Nectin-4. Enfortumab refers to the monoclonal antibody part, and vedotin refers to the payload drug (MMAE) and the linker. The most common side effects for patients taking enfortumab vedotin were fatigue, peripheral neuropathy (nerve damage resulting in tingling or numbness), decreased appetite, rash, alopecia (hair loss), nausea...
Read more Padcev Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Enfortumab_vedotin
Recent Padcev Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 20mg/vial, 30mg/vial